Halofantrine

Halofantrine

Halofantrine Class: Halofantrine is related structurally to quinine and other quinoline-containing blood schizonticides such as chloroquine and mefloquine. Antiparasitic Activity: Halofantrine is effective against chloroquine-sensitive and chloroquine -resistant strains of Plasmodium falciparum. Its principal plasma metabolite, N- desbutylhalofantrine, is also active against sensitive and resistant parasites. Mechanism of Action: Halofantrine may share the same mechanism(s) of action as the 4-aminoquinolin es since it forms a complex with ferriprotoporphyrin IX in vitro and interferes with the degradation of haemoglobin. Mechanism of Resistance : Allelic exchange experiments in the pfmdr1 gene show that changes in Pgh1 can modulate resistance to halofantrine. Pharmacokinetics: Absorption of halofantrine is poor and bioavailability is low. There is wide intra - and inter-subject variability. Halofantrine is bound to low - and high-density lipoproteins in human plasma. The elimination half-life of halofantrine after intravenous administration to malaria patients is 14.4 hours. In convalescence, this value is reduced to 7.5 hours. This value is prolonged in patients with malaria (91-103 hours). Dosage : For adults (<40kg) 3 doses of 500mg (2 x 250mg tablets; 8mg/kg) every six hours. Pregnancy: Halofantrine should not be given in pregnancy unless there is a strong indication. Adverse Effects: The most serious effects of halofantrine relate to QTc prolongation, episodes of torsades de pointes or sudden cardiac de ath. These effects are related to the circulating plasma concentrations of halofantrine and can occur with therapeutic dosages. Pretreatment with mefloquine appears to exacerbate these effects, due possibly to a pharmacokinetic interaction between the two compounds. Drug Interactions: The absorption of halofantrine can be increased dramatically when taken with food. Both Cmax and AUC of halofantrine and desbutylhalofantrine are increased by an order of magnitude after the administration of a 250 mg dose with a fatty meal. .

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    1 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us